Radiocontrast Agent Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Radiocontrast Agent market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period.

    This report presents the market size and development trends by detailing the Radiocontrast Agent market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Radiocontrast Agent market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Radiocontrast Agent industry and will help you to build a panoramic view of the industrial development.

    Radiocontrast Agent Market, By Type:

    • Barium-based Radiocontrast Agent

    • Iodinated Radiocontrast Agent

    • Gadolinium-based Radiocontrast Agent

    Radiocontrast Agent Market, By Application:

    • Radiology

    • Interventional Radiology

    Some of the leading players are as follows:

    • Daiichi Sankyo (Japan)

    • Jodas (India)

    • Lantheus (US)

    • GE Healthcare (US)

    • Unijules Life Sciences (India)

    • Bracco Imaging (Italy)

    • Guerbet (France)

    • Bayer HealthCare (Germany)

    • Taejoon Pharm (South Korea)

    • J.B. Chemicals and Pharmaceuticals (India)

    • Spago Nanomedicine (Sweden)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Radiocontrast Agent Market: Technology Type Analysis

    • 4.1 Radiocontrast Agent Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Radiocontrast Agent Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Barium-based Radiocontrast Agent

      • 4.3.2 Iodinated Radiocontrast Agent

      • 4.3.3 Gadolinium-based Radiocontrast Agent

    5 Radiocontrast Agent Market: Product Analysis

    • 5.1 Radiocontrast Agent Product Market Share Analysis, 2018 & 2026

    • 5.2 Radiocontrast Agent Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Radiocontrast Agent Market: Application Analysis

    • 6.1 Radiocontrast Agent Application Market Share Analysis, 2018 & 2026

    • 6.2 Radiocontrast Agent Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Radiology

      • 6.3.2 Interventional Radiology

    7 Radiocontrast Agent Market: Regional Analysis

    • 7.1 Radiocontrast Agent Regional Market Share Analysis, 2018 & 2026

    • 7.2 Radiocontrast Agent Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Daiichi Sankyo (Japan)

      • 9.1.1 Daiichi Sankyo (Japan) Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Jodas (India)

      • 9.2.1 Jodas (India) Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Lantheus (US)

      • 9.3.1 Lantheus (US) Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 GE Healthcare (US)

      • 9.4.1 GE Healthcare (US) Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Unijules Life Sciences (India)

      • 9.5.1 Unijules Life Sciences (India) Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Bracco Imaging (Italy)

      • 9.6.1 Bracco Imaging (Italy) Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Guerbet (France)

      • 9.7.1 Guerbet (France) Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Bayer HealthCare (Germany)

      • 9.8.1 Bayer HealthCare (Germany) Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Taejoon Pharm (South Korea)

      • 9.9.1 Taejoon Pharm (South Korea) Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 J.B. Chemicals and Pharmaceuticals (India)

      • 9.10.1 J.B. Chemicals and Pharmaceuticals (India) Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Spago Nanomedicine (Sweden)

      • 9.11.1 Spago Nanomedicine (Sweden) Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

     

    The List of Tables and Figures (Totals 88 Figures and 154 Tables)

    • Figure Barium-based Radiocontrast Agent Radiocontrast Agent market, 2015 - 2026 (USD Million)

    • Figure Iodinated Radiocontrast Agent Radiocontrast Agent market, 2015 - 2026 (USD Million)

    • Figure Gadolinium-based Radiocontrast Agent Radiocontrast Agent market, 2015 - 2026 (USD Million)

    • Figure Radiology market, 2015 - 2026 (USD Million)

    • Figure Interventional Radiology market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Radiocontrast Agent market, by country, 2015 - 2026 (USD Million)

    • Table North America Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table North America Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table North America Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Canada Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Canada Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Europe Radiocontrast Agent market, by country, 2015 - 2026 (USD Million)

    • Table Europe Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Europe Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Europe Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Germany Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Germany Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table France Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table France Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Italy Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Italy Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Spain Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Spain Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiocontrast Agent market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table China Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table China Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Japan Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Japan Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table India Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table India Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Radiocontrast Agent market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table MEA Radiocontrast Agent market, by country, 2015 - 2026 (USD Million)

    • Table MEA Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table MEA Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table MEA Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Radiocontrast Agent market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Radiocontrast Agent market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Radiocontrast Agent market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Daiichi Sankyo (Japan) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jodas (India) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lantheus (US) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GE Healthcare (US) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Unijules Life Sciences (India) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bracco Imaging (Italy) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Guerbet (France) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer HealthCare (Germany) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Taejoon Pharm (South Korea) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table J.B. Chemicals and Pharmaceuticals (India) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Spago Nanomedicine (Sweden) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.